Overview

Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)

Status:
Terminated

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

This randomized, single-center, controlled study is designed to evaluate the safety, tolerability, and efficacy of treatment with Peg-Intron with Rebetol in methadone or buprenorphine maintenance patients with hepatitis C.

Phase:

Phase 4

Details

Lead Sponsor:

Indivior Inc.

Collaborator:

AESCA Pharma GmbH

Treatments:

Buprenorphine
Interferon alpha-2
Interferon-alpha
Interferons
Methadone
Peginterferon alfa-2b
Ribavirin